A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis. (Q47407342)

15 January 2018

title

A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis. (English)

1 reference

15 January 2018

0 references

0 references

0 references

1 reference

W-C Hsiao

1

1 reference

15 January 2018

K-S Shia

2

1 reference

15 January 2018

Y-T Wang

3

1 reference

15 January 2018

Y-N Yeh

4

1 reference

15 January 2018

C-P Chang

5

1 reference

15 January 2018

Y Lin

6

1 reference

15 January 2018

P-H Chen

7

1 reference

15 January 2018

C-H Wu

8

1 reference

15 January 2018

Y-S Chao

9

1 reference

15 January 2018

M-S Hung

10

1 reference

15 January 2018

publication date

25 February 2015

1 reference

15 January 2018

Diabetes, Obesity and Metabolism

published in

1 reference

15 January 2018

volume

17

1 reference

15 January 2018

page(s)

495-504

1 reference

15 January 2018

issue

5

1 reference

15 January 2018

Endocannabinoid control of food intake and energy balance

cites work

1 reference

CB1 antagonists for obesity--what lessons have we learned from rimonabant?

21 January 2018

1 reference

CB1 receptor blockade and its impact on cardiometabolic risk factors: overview of the RIO programme with rimonabant

21 January 2018

1 reference

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

21 January 2018

1 reference

The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders

21 January 2018

1 reference

The cannabinoid receptor 1 and its role in influencing peripheral metabolism.

21 January 2018

1 reference

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

21 January 2018

1 reference

Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets

21 January 2018

1 reference

Activation of the peripheral endocannabinoid system in human obesity

21 January 2018

1 reference

Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects.

21 January 2018

1 reference

Cannabinoids induce pancreatic β-cell death by directly inhibiting insulin receptor activation

21 January 2018

1 reference

Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes

21 January 2018

1 reference

Peripherally restricted CB1 receptor blockers

21 January 2018

1 reference

Discovery of 1-(2,4-dichlorophenyl)-N-(piperidin-1-yl)-4-((pyrrolidine-1-sulfonamido)methyl)-5-(5-((4-(trifluoromethyl)phenyl)ethynyl)thiophene-2-yl)-1H-pyrazole-3-carboxamide as a novel peripherally restricted cannabinoid-1 receptor antagonist with

21 January 2018

1 reference

Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.

21 January 2018

1 reference

Discovery of 1-(2,4-dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide as a potential peripheral cannabinoid-1 receptor inverse agonist

21 January 2018

1 reference

Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors.

21 January 2018

1 reference

The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats

21 January 2018

1 reference

Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors

21 January 2018

1 reference

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

21 January 2018

1 reference

Endocannabinoids as physiological regulators of colonic propulsion in mice

21 January 2018

1 reference

Investigation on the relationship between cannabinoid CB1 and opioid receptors in gastrointestinal motility in mice

21 January 2018

1 reference

Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance

21 January 2018

1 reference

Endocannabinoid signal in the gut controls dietary fat intake.

21 January 2018

1 reference

Biphasic suppression of appetite by cannabinoid CB1 receptor antagonists with distinct functional activities.

21 January 2018

1 reference

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

21 January 2018

1 reference

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

21 January 2018

1 reference

Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves

21 January 2018

1 reference

CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance

21 January 2018

1 reference

Signalling mechanisms regulating lipolysis

21 January 2018

1 reference

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

21 January 2018

1 reference

Receptor-mediated regional sympathetic nerve activation by leptin.

21 January 2018

1 reference

Adaptive thermogenesis in adipocytes: is beige the new brown?

21 January 2018

1 reference

The β2-adrenoceptor agonist formoterol stimulates mitochondrial biogenesis

21 January 2018

1 reference

Multiple signalling pathways involved in beta2-adrenoceptor-mediated glucose uptake in rat skeletal muscle cells.

21 January 2018

1 reference

β(2)-Adrenoceptors increase translocation of GLUT4 via GPCR kinase sites in the receptor C-terminal tail

21 January 2018

1 reference

21 January 2018

1 reference

Adrenergic receptor polymorphisms and autonomic nervous system function in human obesity

21 January 2018

1 reference

Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells

21 January 2018

1 reference

Multiple lipolysis defects in the insulin resistance (metabolic) syndrome

21 January 2018

1 reference

Formoterol, a highly β2-selective agonist, increases energy expenditure and fat utilisation in men.

21 January 2018

1 reference

TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DOM.12447

1 reference

15 January 2018

PubMed ID

25656402

1 reference

15 January 2018